]>
IRCT20200428047229N3 IRCT 2020-11-25 Shahid Beheshti University of Medical Sciences Effect of cupping on respiratory symptoms of COVID-19 Investigating the effect of cupping therapy on respiratory symptoms of patients with COVID-19 2020-09-08 anticipated 72 Complete https://irct.ir/trial/51516 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: At first due to the inclusion criteria, infectious diseases specialist diagnosis, and positive PCR test, and Samples will be randomly assigned to four blocks using Random Allocation Software. Blocking and allocation sequences for concealment will be done by the non-involved researcher (Allocation Concealment). The sample allocation ratio will be Allocation 1:1 and will be divided into two groups of receiving cupping and control group (Assignment). Then based on blocks and allocation sequences cupping therapy will be given to patients. This is an open-label study and blinding will not happen. 3 COVID-19. Intervention 1: Intervention group: Patients in this group receive the treatment of COVID-19 according to the protocol of the Ministry of Health, in addition, they should receive cupping therapy using special disposable plastic cups for cupping therapy, for each patient, for 5 days, once a day for 15 to 20 minutes in the back of the chest (3 glasses on each side). Intervention 2: Control group: Patients in this group receive medication for COVID-19 according to the Ministry of Health protocol. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no more information.
public Hanieh Tahermohammadi
Faculty of Traditional Medicine, Shams Alley, Tavanir Station, Valiasr St., Tehran Town
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 dr.hmohammadi@sbmu.ac.ir Shahid Beheshti University of Medical Sciences scientific Mojgan Tansaz
No.8 Shams Alley, opposite Street Tavanir, Vali Asr Street, Tehran
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 Tansaz_mojgan@yahoo.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Patients aged 18 to 60 years Diagnosis confirmation by the cooperative infectious disease specialist in the project Patient's consent to participate in the project With inpatient clinical criteria (fever above 38° C or severe cough or shortness of breath or respiratory rate more than 24 per minute or oxygen saturation lower than 93%) Positive PCR 18 years 60 years Both Current incidence of coagulopathy, obesity, deep vein thrombosis, vertebral fracture or herniated disc Need for current hospitalization in ICU Pregnancy Breastfeeding Hearth failure Chronic renal failure Receive chemotherapy Receive corticosteroids Immune deficiency Open wound at the site of cupping U07.1 COVID-19, virus identified Treatment - Devices Treatment - Devices Intervention group: Patients in this group receive the treatment of COVID-19 according to the protocol of the Ministry of Health, in addition, they should receive cupping therapy using special disposable plastic cups for cupping therapy, for each patient, for 5 days, once a day for 15 to 20 minutes in the back of the chest (3 glasses on each side). Control group: Patients in this group receive medication for COVID-19 according to the Ministry of Health protocol. Dyspnea. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of cupping. Method of measurement: By using a pulse oximeter and asking the patient. Fever. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: Mercury thermometer (oral). Muscular pain. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the cupping. Method of measurement: By asking the patient and the Visual Analog Scale (VAS) score. Dry cough. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the cupping. Method of measurement: By asking the patient. ESR. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Sed rate device. CRP. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Agglutination kit. Cell blood count. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Cell Counter device. Chest X-ray. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Radiology set. Chest CT scan. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day, if requested by the treating physician, it will be recorded. Method of measurement: CT scan set. Shahid Beheshti University of Medical Sciences Approved 2020-09-08 Ethics committee of Vice-Chancellor in Research Affairs - Shahid Beheshti University of Medical Scie Floor 13, Block A, Ministry of Health & Medical Education Headquarters, Between Zarafashan & South Falamak, Qods Town Tehran Tehran Iran (Islamic Republic of)